FEATURED
Biotech firms raise $12.6B investment in H1 of 2020
Biotechnology has spearheaded the healthcare industry in investment action from private equity and venture capital during the first half of
DEALS
Merck to licence two preclinical immuno oncology programs from F-star
Two additional preclinical discovery programs will be added to the Merck KGaA and F-star Therapeutics collaboration. Merck KGaA, Darmstadt, Germany
PRESS RELEASES
BioMed Raises $177M to Accelerate Next-Gen Biologics Development
Harbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Comments & Analysis
Biotech firms raise $12.6B investment in H1 of 2020
Biotechnology has spearheaded the healthcare industry in investment action from private equity and venture capital during the first half of
RESOURCES
Download the latest pharmaceutical case studies, white papers, research papers and product brochures
Tablet Formulation Guide
Excipient selection for tablet formulation A JRS Pharma White Paper The Tablet Formulation Guide simplifies and optimizes the excipient and
LATEST PROJECTS
Life Sciences Laboratory, Merck, Buchs, Switzerland
Merck KGaA has revealed plans to construct a new €18 million life sciences laboratory facility in Buchs, Switzerland. New laboratory
CLINICAL TRIALS
Lilly starts Phase 3 Trial of monoclonal antibody for COVID-19 prevention
Eli Lilly and Company announced the start of BLAZE-2, a Phase 3 study of the monoclonal antibody LY-CoV555 vaccine candidate
Sponsored by
